High-dose-rate brachytherapy as a monotherapy for prostate cancer-Single-institution results of the extreme fractionation regimen

Article ID	Journal	Published Year	Pages	File Type
3976789	Brachytherapy	2015	7 Pages	PDF

Abstract

HDR brachytherapy as monotherapy for localized prostate cancer was feasible, effective, and had acceptable toxicity profile.

Keywords

High-dose-rate brachytherapy Prostate cancer Toxicity Outcomes Monotherapy

Related Topics

Health Sciences Medicine and Dentistry Oncology

$High-dose-rate brachytherapy as a monotherapy for prostate cancer-Single-institution results of the extreme fractionation regimen$

Authors

Andrzej Marek KukieÅka, Tomasz DÄbrowski, Tomasz Walasek, Agnieszka Olchawa, Roksana Kudzia, Dorota Dybek,